Search clinical trials for: oral vinorelbine and capecitabine
Total 9274 results
-
University of AarhusPierre Fabre LaboratoriesCompleted
-
Cancer Institute and Hospital, Chinese Academy...Recruiting
-
Zhiyong YuNot yet recruitingPathologic Residual Cancer CellsChina
-
Hellenic Oncology Research GroupUniversity Hospital of CreteCompletedMetastatic Breast CancerGreece
-
Suzhou Suncadia Biopharmaceuticals Co., Ltd.TerminatedTriple Negative Breast CancerChina
-
Mario Negri Institute for Pharmacological ResearchTerminatedTriple Negative Breast CancerSpain, Italy, Portugal
-
European Organisation for Research and Treatment...TerminatedBreast CancerFrance, Belgium, United Kingdom, Slovenia, Germany
-
Fudan UniversityCompletedBreast Cancer | Metastasis, NeoplasmChina
-
Cancer Institute and Hospital, Chinese Academy...Hoffmann-La RocheUnknownCarcinoma, Invasive Ductal, BreastChina
-
Swiss Group for Clinical Cancer ResearchCompleted
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedBreast CancerUnited States
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Not yet recruitingHER2-positive Advanced Breast Cancer
-
Fudan UniversityNot yet recruiting
-
Pierre Fabre MedicamentCompleted
-
Shanghai Escugen Biotechnology Co., LtdNot yet recruitingMetastatic Breast CancerChina
-
Sun Yat-sen UniversityCompletedHER2 Positive Breast CancerChina
-
Sponsor GmbHGlaxoSmithKline; iOMEDICO AG; Arbeitsgemeinschaft fur Internistische Onkologie; Arbeitskreis Klinische StudienTerminatedMetastatic Breast Cancer | HER2 Positive | First or Second Line Therapy | Failure or Contraindication of Trastuzumab TherapyGermany
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNot yet recruiting
-
Fudan UniversityNot yet recruitingTriple-negative Breast Cancer
-
Guangdong Association of Clinical TrialsTerminatedLung Neoplasm MalignantChina
-
Gilead SciencesParexel; Iqvia Pty Ltd; Medidata SolutionsActive, not recruitingMetastatic Breast CancerKorea, Republic of, Taiwan, China
-
Pierre Fabre Pharma GmbHWinicker Norimed GmbHCompletedBreast Cancer | Non-Small-Cell Lung CancerGermany, Austria
-
National Cancer Centre, SingaporeCompletedNon-Small Cell Lung CancerSingapore
-
Henan Cancer HospitalNot yet recruitingAdvanced Breast Cancer | Treatment | HR Low/HER2 Negative
-
Cedars-Sinai Medical CenterNational Institute on Aging (NIA)RecruitingStroke | Atrial FibrillationUnited States
-
Fujian Cancer HospitalNot yet recruitingNSCLC | EGFR | Third-generation TKI
-
Yan XueRecruiting
-
Istituto Scientifico Romagnolo per lo Studio e...Pierre Fabre LaboratoriesTerminatedCarcinoma, Non-Small-Cell Lung | Secondary | Advanced Stage IIIB | High Thymidylate Synthase ExpressionItaly
-
Centre Oscar LambretNational Cancer Institute, France; Pierre Fabre LaboratoriesCompleted
-
RemeGen Co., Ltd.Recruiting
-
Ludwig-Maximilians - University of MunichCompleted
-
The First Affiliated Hospital with Nanjing Medical...Recruiting
-
Hellenic Cooperative Oncology GroupUniversity of IoanninaCompletedBreast Cancer | Prostate Cancer | Non Small Cell Lung CancerGreece
-
National Cancer Institute, NaplesTerminatedAdvanced Non-Small Cell Lung CancerItaly
-
European Institute of OncologyRecruiting
-
Baylor Research InstituteCompletedMetastatic Breast CancerUnited States
-
Zai Lab (Shanghai) Co., Ltd.Active, not recruiting
-
AmgenUnknown
-
Cancer Institute and Hospital, Chinese Academy...UnknownHormone Receptor Positive Advanced Breast CancerChina
-
Eye & ENT Hospital of Fudan UniversityRecruitingto Explore Whether the Adjuvant Therapy of Metronomic Capecitabine Could Improve the Disease-free Survival of Locoregionally Advanced Hypopharyngeal CarcinomaChina
-
First Affiliated Hospital of Harbin Medical UniversitySponsor GmbHUnknown
-
Cancer Research Group - Collaborative Group, Beirut...Unknown
-
Henan Cancer HospitalRecruiting
-
Fujian Cancer HospitalEnrolling by invitationEGFR/ ALK-negative Advanced NSCLCChina
-
Fudan UniversityRecruitingTriple-Negative Breast CancerChina
-
US Oncology ResearchGenentech, Inc.TerminatedBreast Neoplasms | Malignant Tumor of the BreastUnited States
-
Latin American Cooperative Oncology GroupGlaxoSmithKlineCompletedBRMS1 | Performance Status Zero to Two for Beginning the Study | Patient With a Maximum of One Chemotherapy | Patient With Progression After TaxanesArgentina, Brazil, Peru
-
Jiangsu Alphamab Biopharmaceuticals Co., LtdNot yet recruiting
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); Northwestern Memorial HospitalCompletedMetastatic CancerUnited States
-
Cancer Institute and Hospital, Chinese Academy...Not yet recruitingHuman Epidermal Growth Factor 2 Negative Carcinoma of Breast